Cardiac Left Ventricular miRNA-26a Is Downregulated in Ovariectomized Mice, Upregulated upon 17-Beta Estradiol Replacement, and Inversely Correlated with Collagen Type 1 Gene Expression
Open Access
- 9 May 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (10) , 5153
Abstract
Heart failure with preserved ejection fraction (HFpEF) is more prevalent in post- compared to pre-menopausal women. The underlying mechanisms are not fully understood. Data in humans is confounded by age and co-morbidities. We investigated the effects of ovariectomy and estrogen replacement on the left ventricular (LV) gene expression of pro-inflammatory and pro-fibrotic factors involved in HFpEF and putative regulating miRNAs. Nine-week-old C57BL/6 female mice were subjected to ovariectomy (OVX) or SHAM operation. OVX and SHAM groups were sacrificed 1-, 6-, and 12-weeks post-surgery (T1/SHAM; T1/OVX; T6/SHAM; T6/OVX, T12/SHAM). 17β-estradiol (E2) or vehicle (VEH) was then administered to the OVX groups for 6 weeks (T12/OVX/E2; T12/OVX/VEH). Another SHAM group was sacrificed 12-weeks post-surgery. RNA and miRNAs were extracted from the LV apex. An early 3-fold increase in the gene expression of IL-1α, IL-6, Mmp9, Mmp12, Col1α1, and Col3α1 was observed one-week post-surgery in T1/OVX vs. T1/SHAM, but not at later time points. miRNA-26a was lower in T1/OVX vs. T1/SHAM and was inversely correlated with Col1α1 and Col3α1 expression 1-week post-surgery (r = −0.79 p < 0.001; r = −0.6 p = 0.007). miRNAs-26a, 29b, and 133a were significantly higher, while Col1α1, Col3α1, IL-1α, IL-6, Tnfα, Mmp12, and FasL gene expression was significantly lower in E2- compared to vehicle-treated OVX mice. miRNA-26a was inversely correlated with Col3α1 in T12/OVX/ E2 (r = −0.56 p = 0.02). OVX triggered an early increase in the gene expression of pro-inflammatory and pro-fibrotic factors, highlighting the importance of the early phase post-cessation of ovarian function. E2 replacement therapy, even if it was not immediately initiated after OVX, reversed these unfavorable changes and upregulated cardiac miRNA-26a, previously unknown to be affected by menopausal status.Keywords
Funding Information
- Linda Joy Pollin Cardiovascular Wellness Center for Women, Division of Cardiology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
This publication has 35 references indexed in Scilit:
- Ovariectomized rodents as a menopausal metabolic syndrome model. A minireviewMolecular and Cellular Biochemistry, 2020
- Connecting sex differences, estrogen signaling, and microRNAs in cardiac fibrosisJournal of Molecular Medicine, 2019
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targetsMolecular and Cellular Endocrinology, 2015
- 17β-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function: A preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutationThe Journal of Steroid Biochemistry and Molecular Biology, 2015
- An emerging role for the miR-26 family in cardiovascular diseaseTrends in Cardiovascular Medicine, 2014
- Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heartInternational Journal of Cardiology, 2013
- NF‐κB mediated miR‐26a regulation in cardiac fibrosisJournal of Cellular Physiology, 2012
- Enhanced cardiac inflammation and fibrosis in ovariectomized hypertensive rats: a possible mechanism of diastolic dysfunction in postmenopausal womenHypertension Research, 2011
- Role of Gender in Heart Failure with Normal Left Ventricular Ejection FractionProgress in Cardiovascular Diseases, 2007